Immune Thrombocytopenia (ITP) Therapy
J15 · Effective Apr 1, 2020
2 active Medicare policies list J8499, and 8 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Apr 1, 2020
National · Effective Apr 16, 2026
8 policies from 8 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of J8499 |
|---|---|---|
| Sublingual Immunotherapy as a Technique of Allergen-Specific Therapy | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J8499 |
|---|---|---|
| Sublingual Immunotherapy as a Technique of Allergen-Specific Therapy | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J8499 |
|---|---|---|
| Sublingual Immunotherapy as a Technique of Allergen-Specific Therapy | Jan 1, 2026 |
| Covered |
| Policy | Effective | Status of J8499 |
|---|---|---|
| Sublingual Immunotherapy as a Technique of Allergen-Specific Therapy | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J8499 |
|---|---|---|
| Cigna MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J8499 |
|---|---|---|
| Chelation Therapy | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J8499 |
|---|---|---|
| Chelation Therapy | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J8499 |
|---|---|---|
| Chelation Therapy | Jul 1, 2026 | Covered |